Niladry Sekhar Ghosh
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Niladry Sekhar Ghosh has a total of 51 co-authors. Here are the top co-authors by number of shared publications:
Ranjit Singh
AVIPS, Shobhit University Saharanpur Uttar Pradesh India
5 shared publications- Anubhav Dubey
Department of Pharmacology, Maharana Pratap College of Pharmacy, Kanpur, Uttar Pradesh, India
3 shared publications Anubhav Dubey
Dept. of Pharmacology Maharana Pratap College of Pharmacy Kanpur Uttar Pradesh India
2 shared publications- Dharmendra Kumar
Narayan Institute of Pharmacy, Gopal Narayan Singh University, Jamuhar, Sasaram, Rohtas-821305, Bihar, India
2 shared publications Ekta Pandey
Bundelkhand Institute of Engineering and Technology Jhansi, UP- 284128
2 shared publications- Jyoti Monga
Ch Devi Lal College of Pharmacy, Jagadhri, Haryana, India
2 shared publications
Latest Publications
- 4 March 2026
- Published by Springer Nature in Molecular Diversity
- Vol. 30 (4) , 5053-5066
Current advances in 7-hydroxycoumarin derivatives as potential therapeutic agents for Alzheimer’s disease
Alzheimer’s disease (AD), a multifactorial neurodegenerative disorder, remains a major cause of cognitive decline in the aging population. Current pharmacological interventions provide only symptomatic relief, highlighting the urgent need for novel therapeutic strategies capable of modifying disease progression. Coumarins, particularly 7-hydroxycoumarin and its synthetic derivatives, have attracted considerable interest due to their broad pharmacological potential, including cholinesterase inhibition, monoamine oxidase (MAO) inhibition, antioxidant, anti-amyloidogenic and metal-chelating activities. This review presents a comprehensive analysis of synthetic 7-hydroxycoumarin derivatives reported over the past 15 years as potential anti-Alzheimer agents, classifying them according to their actions on key pathological hallmarks of AD, such as acetylcholinesterase (AChE), butyrylcholinesterase (BuChE), MAO-B, β-amyloid (Aβ) aggregation, oxidative stress and neuroinflammation. Structure–activity relationship (SAR) analysis reveals that substitutions at the 7-, 3- and 4-positions of the coumarin scaffold critically influence pharmacological potency and selectivity, with aromatic and alkyl amine substitutions generally enhancing enzyme inhibition and neuroprotective effects. Several derivatives exhibited sub-micromolar to nanomolar inhibitory activity against AChE and MAO-B, along with antioxidant and anti-Aβ aggregation properties, supporting their multifunctional behaviour. Overall, this review highlights the therapeutic promise of 7-hydroxycoumarin derivatives as multitarget-directed ligands (MTDLs) and provides valuable insights for the rational design of new lead compounds for Alzheimer’s disease. Graphical abstract
- 4 March 2026
- Published by Springer Nature in Molecular Diversity
- Vol. 30 (4) , 5053-5066
Current advances in 7-hydroxycoumarin derivatives as potential therapeutic agents for Alzheimer’s disease
Alzheimer’s disease (AD), a multifactorial neurodegenerative disorder, remains a major cause of cognitive decline in the aging population. Current pharmacological interventions provide only symptomatic relief, highlighting the urgent need for novel therapeutic strategies capable of modifying disease progression. Coumarins, particularly 7-hydroxycoumarin and its synthetic derivatives, have attracted considerable interest due to their broad pharmacological potential, including cholinesterase inhibition, monoamine oxidase (MAO) inhibition, antioxidant, anti-amyloidogenic and metal-chelating activities. This review presents a comprehensive analysis of synthetic 7-hydroxycoumarin derivatives reported over the past 15 years as potential anti-Alzheimer agents, classifying them according to their actions on key pathological hallmarks of AD, such as acetylcholinesterase (AChE), butyrylcholinesterase (BuChE), MAO-B, β-amyloid (Aβ) aggregation, oxidative stress and neuroinflammation. Structure–activity relationship (SAR) analysis reveals that substitutions at the 7-, 3- and 4-positions of the coumarin scaffold critically influence pharmacological potency and selectivity, with aromatic and alkyl amine substitutions generally enhancing enzyme inhibition and neuroprotective effects. Several derivatives exhibited sub-micromolar to nanomolar inhibitory activity against AChE and MAO-B, along with antioxidant and anti-Aβ aggregation properties, supporting their multifunctional behaviour. Overall, this review highlights the therapeutic promise of 7-hydroxycoumarin derivatives as multitarget-directed ligands (MTDLs) and provides valuable insights for the rational design of new lead compounds for Alzheimer’s disease. Graphical abstract
- Open Access
- 30 January 2026
- Published by Informatics Publishing Limited in Journal of Natural Remedies
- p. 39-56
Eichhornia crassipes (Water Hyacinth) Multifaceted Potential due to Many Therapeutic and Value-added Aspects
Background: Eichhornia crassipes, more often known as the water hyacinth, a member of the Pontederiaceae family, is a notoriously invasive macrophyte that inhabits watery habitats. Areas in the tropics and subtropics are its native habitats. Despite its pejorative reputation, water hyacinth causes major ecological issues, such as the depletion of water supplies. It serves a variety of purposes. Animal feed, bioenergy, biofertilizer, and industrial wastewater treatment are only a few of its numerous societal and economic applications. Aim: To identify research gaps and highlight the need for more extensive pharmacological investigations on this medicinal plant. Methods: We performed a literature search on ScienceDirect and PubMed databases using various keywords, including “water hyacinth”. The search was refined by applying relevant filters to obtain the most pertinent articles for this review article’s objective. Results: Alkaloids, sterols, tannins, saponins, flavonoids, phenols, and water hyacinth are just a few of the many bioactive plant components found in abundance in this plant. Many different medicinal effects have been associated with these secondary metabolites. Among its many pharmacological effects are those of an antioxidant, anti-inflammatory, antibacterial, neuroprotective, and hepatoprotective nature, among many others. Conclusion: The E. crassipes (Mart.) plant’s pharmacologically active components have been the subject of much study. It still needs to carry out an extensive investigation of the pharmacological properties of this medicinal plant. This review provides a thorough synopsis of the literature on E. crassipes, including its traditional usage, pharmacological and biological properties, and chemical composition. Major Findings: Eichhornia crassipes contains a rich spectrum of secondary metabolites, including alkaloids, sterols, tannins, saponins, flavonoids, and phenolic compounds. These phytochemicals demonstrate diverse pharmacological effects, such as antioxidant, anti-inflammatory, antibacterial, neuroprotective, and hepatoprotective activities.
- 30 January 2026
- Published by Informatics Publishing Limited in Journal of Natural Remedies
- p. 39-56
Open AccessEichhornia crassipes (Water Hyacinth) Multifaceted Potential due to Many Therapeutic and Value-added Aspects
Background: Eichhornia crassipes, more often known as the water hyacinth, a member of the Pontederiaceae family, is a notoriously invasive macrophyte that inhabits watery habitats. Areas in the tropics and subtropics are its native habitats. Despite its pejorative reputation, water hyacinth causes major ecological issues, such as the depletion of water supplies. It serves a variety of purposes. Animal feed, bioenergy, biofertilizer, and industrial wastewater treatment are only a few of its numerous societal and economic applications. Aim: To identify research gaps and highlight the need for more extensive pharmacological investigations on this medicinal plant. Methods: We performed a literature search on ScienceDirect and PubMed databases using various keywords, including “water hyacinth”. The search was refined by applying relevant filters to obtain the most pertinent articles for this review article’s objective. Results: Alkaloids, sterols, tannins, saponins, flavonoids, phenols, and water hyacinth are just a few of the many bioactive plant components found in abundance in this plant. Many different medicinal effects have been associated with these secondary metabolites. Among its many pharmacological effects are those of an antioxidant, anti-inflammatory, antibacterial, neuroprotective, and hepatoprotective nature, among many others. Conclusion: The E. crassipes (Mart.) plant’s pharmacologically active components have been the subject of much study. It still needs to carry out an extensive investigation of the pharmacological properties of this medicinal plant. This review provides a thorough synopsis of the literature on E. crassipes, including its traditional usage, pharmacological and biological properties, and chemical composition. Major Findings: Eichhornia crassipes contains a rich spectrum of secondary metabolites, including alkaloids, sterols, tannins, saponins, flavonoids, and phenolic compounds. These phytochemicals demonstrate diverse pharmacological effects, such as antioxidant, anti-inflammatory, antibacterial, neuroprotective, and hepatoprotective activities.
- Open Access
- 27 November 2025
- Published by Informatics Publishing Limited in Journal of Natural Remedies
- p. 2785-2793
Hypolipidemic Potentials of Methanolic Extract of Cymbopogon flexuosus
Background: Hyperlipidemia is a condition marked by high levels of Total Cholesterol (TC), Low-Density Lipoprotein (LDL), and Very Low-Density Lipoprotein (VLDL), along with reduced levels of High-Density Lipoprotein (HDL) in the blood. Aim: This study aimed to evaluate the cholesterol-lowering (hypolipidemic) effect of methanolic extract from Cymbopogon flexuosus leaves in rats fed a high-cholesterol diet. Methods: The anti-hyperlipidemic effects of the extract were tested in rats over 45 days. Antioxidant activity was also assessed using DPPH and hydrogen peroxide free radical scavenging assays. Results: When cholesterol was given to rats for 45 days, the activities of alanine aminotransferase, aspartate aminotransferase, and alkaline phosphatase significantly increased, and the amounts of lipids in the tissues and plasma increased while HDL cholesterol dropped. Additionally, it lowered superoxide dismutase activity in the tissues and increased malondialdehyde levels. Co-administration of Cymbopogon flexuosus extract at doses of 100 and 200 mg/kg, however, dramatically restored lipid levels to nearly normal in rats fed high cholesterol. HDL cholesterol levels increased by 225.44% and 110.39%, while plasma, liver, heart, kidney, and lung cholesterol decreased by 23.13% and 56.43%, 30.09% and 20.90%, 38.21% and 74.53%, 12.61% and 32.49%, and 37.11% and 29.90%, respectively. While SOD activity in the liver, heart, kidney, and lung increased by 89.35% and 149.21%, 74.91% and 68.35%, 56.76% and 114.77%, and 204.91% and 274.62%, respectively, the levels of AST, ALT, and ALP in the plasma and MDA in the tissues similarly reduced. Conclusions: This study’s findings corroborate previous research showing that Cymbopogon flexuosus can reduce lipid levels in rats given a high-cholesterol diet. Major Finding: The study found that Cymbopogon flexuosus (lemongrass) can help lower fat levels in the blood and also acts as an antioxidant. These results suggest that the plant could be a promising natural treatment for high cholesterol.
- 27 November 2025
- Published by Informatics Publishing Limited in Journal of Natural Remedies
- p. 2785-2793
Open AccessHypolipidemic Potentials of Methanolic Extract of Cymbopogon flexuosus
Background: Hyperlipidemia is a condition marked by high levels of Total Cholesterol (TC), Low-Density Lipoprotein (LDL), and Very Low-Density Lipoprotein (VLDL), along with reduced levels of High-Density Lipoprotein (HDL) in the blood. Aim: This study aimed to evaluate the cholesterol-lowering (hypolipidemic) effect of methanolic extract from Cymbopogon flexuosus leaves in rats fed a high-cholesterol diet. Methods: The anti-hyperlipidemic effects of the extract were tested in rats over 45 days. Antioxidant activity was also assessed using DPPH and hydrogen peroxide free radical scavenging assays. Results: When cholesterol was given to rats for 45 days, the activities of alanine aminotransferase, aspartate aminotransferase, and alkaline phosphatase significantly increased, and the amounts of lipids in the tissues and plasma increased while HDL cholesterol dropped. Additionally, it lowered superoxide dismutase activity in the tissues and increased malondialdehyde levels. Co-administration of Cymbopogon flexuosus extract at doses of 100 and 200 mg/kg, however, dramatically restored lipid levels to nearly normal in rats fed high cholesterol. HDL cholesterol levels increased by 225.44% and 110.39%, while plasma, liver, heart, kidney, and lung cholesterol decreased by 23.13% and 56.43%, 30.09% and 20.90%, 38.21% and 74.53%, 12.61% and 32.49%, and 37.11% and 29.90%, respectively. While SOD activity in the liver, heart, kidney, and lung increased by 89.35% and 149.21%, 74.91% and 68.35%, 56.76% and 114.77%, and 204.91% and 274.62%, respectively, the levels of AST, ALT, and ALP in the plasma and MDA in the tissues similarly reduced. Conclusions: This study’s findings corroborate previous research showing that Cymbopogon flexuosus can reduce lipid levels in rats given a high-cholesterol diet. Major Finding: The study found that Cymbopogon flexuosus (lemongrass) can help lower fat levels in the blood and also acts as an antioxidant. These results suggest that the plant could be a promising natural treatment for high cholesterol.
- Open Access
- 10 November 2025
- Published by IP Innovative Publication Pvt Ltd in International Journal of Pharmaceutical Chemistry and Analysis
- Vol. 12 (3) , 131–144
Natural and synthetic polymers: A comprehensive review of their applications in drug delivery and pharmaceutical research
Medical Publisher in Delhi, India - IP Innovative Publication Pvt Limited, Medical Journals Publication, Open Access Journals, Print Journals,Indian Journals, Surgery, Microbiology, Anaesthesia, Anatomy Biochemistry Books and Journals, Skills for Employability,Best Journal Publishers-IP Innovative Publication Pvt Limit
- 10 November 2025
- Published by IP Innovative Publication Pvt Ltd in International Journal of Pharmaceutical Chemistry and Analysis
- Vol. 12 (3) , 131–144
Open AccessNatural and synthetic polymers: A comprehensive review of their applications in drug delivery and pharmaceutical research
Medical Publisher in Delhi, India - IP Innovative Publication Pvt Limited, Medical Journals Publication, Open Access Journals, Print Journals,Indian Journals, Surgery, Microbiology, Anaesthesia, Anatomy Biochemistry Books and Journals, Skills for Employability,Best Journal Publishers-IP Innovative Publication Pvt Limit
- 1 October 2025
- Published by Springer Nature in Medical Oncology
- Vol. 42 (11) , 1-12
Exploring the role of Cathepsin S in mitochondrial energy metabolism: implications for cancer progression and therapeutic targeting
Cathepsin S (CTSS) is a lysosomal cysteine protease traditionally recognized for its roles in protein degradation and immune responses, but emerging evidence highlights its critical involvement in cancer progression through the regulation of mitochondrial energy metabolism, tumor microenvironment modulation, and apoptosis. CTSS regulates mitochondrial calcium uptake by controlling the mitochondrial calcium uniporter (MCU), thus maintaining mitochondrial membrane potential and oxidative phosphorylation (OXPHOS). Inhibition of CTSS leads to mitochondrial calcium overload, increased reactive oxygen species (ROS) generation, impaired autophagy, and apoptosis, as demonstrated particularly in glioblastoma models. Additionally, CTSS promotes cancer progression by degrading extracellular matrix components, stimulating angiogenesis, and facilitating invasion and metastasis. Selective CTSS inhibitors enhance chemotherapy sensitivity and reduce tumor growth in various preclinical cancer models, including both glycolytic and OXPHOS-dependent tumors. However, most data originate from preclinical studies, limiting immediate clinical applicability. Moreover, CTSS inhibition may elevate ROS levels, posing potential harm to normal cells, and the complex tumor microenvironment presents challenges for targeted therapies. Overall, CTSS is a pivotal regulator that integrates mitochondrial function with tumor microenvironment dynamics, making it a promising therapeutic target. It represents a compelling target for future precision oncology strategies, offering dual benefits of direct tumor suppression and improved sensitivity to existing therapies. Nevertheless, further mechanistic studies and clinical validation are required to fully exploit CTSS’s potential in cancer treatment, including deeper investigation into the molecular events linking CTSS inhibition to changes in autophagy, mitochondrial biogenesis, and metabolic reprogramming across diverse cancer subtypes.
- 1 October 2025
- Published by Springer Nature in Medical Oncology
- Vol. 42 (11) , 1-12
Exploring the role of Cathepsin S in mitochondrial energy metabolism: implications for cancer progression and therapeutic targeting
Cathepsin S (CTSS) is a lysosomal cysteine protease traditionally recognized for its roles in protein degradation and immune responses, but emerging evidence highlights its critical involvement in cancer progression through the regulation of mitochondrial energy metabolism, tumor microenvironment modulation, and apoptosis. CTSS regulates mitochondrial calcium uptake by controlling the mitochondrial calcium uniporter (MCU), thus maintaining mitochondrial membrane potential and oxidative phosphorylation (OXPHOS). Inhibition of CTSS leads to mitochondrial calcium overload, increased reactive oxygen species (ROS) generation, impaired autophagy, and apoptosis, as demonstrated particularly in glioblastoma models. Additionally, CTSS promotes cancer progression by degrading extracellular matrix components, stimulating angiogenesis, and facilitating invasion and metastasis. Selective CTSS inhibitors enhance chemotherapy sensitivity and reduce tumor growth in various preclinical cancer models, including both glycolytic and OXPHOS-dependent tumors. However, most data originate from preclinical studies, limiting immediate clinical applicability. Moreover, CTSS inhibition may elevate ROS levels, posing potential harm to normal cells, and the complex tumor microenvironment presents challenges for targeted therapies. Overall, CTSS is a pivotal regulator that integrates mitochondrial function with tumor microenvironment dynamics, making it a promising therapeutic target. It represents a compelling target for future precision oncology strategies, offering dual benefits of direct tumor suppression and improved sensitivity to existing therapies. Nevertheless, further mechanistic studies and clinical validation are required to fully exploit CTSS’s potential in cancer treatment, including deeper investigation into the molecular events linking CTSS inhibition to changes in autophagy, mitochondrial biogenesis, and metabolic reprogramming across diverse cancer subtypes.
- 16 September 2025
- Published by Wiley in Applied Organometallic Chemistry
- Vol. 39 (10)
Eco‐Friendly ZnO Nanoparticle Synthesis and Colostrum Coating: Structural Insights and Biomedical Potential
The eco‐friendly synthesis of zinc oxide nanoparticles (ZnONPs) using Grewia asiatica stem extract and their subsequent coating with freeze‐dried bovine colostrum powder was explored for biomedical and environmental applications. This study investigated the role of phytochemicals as natural reducing and stabilizing agents in ZnONP synthesis, while also evaluating the structural and functional impact of colostrum coating. Ultraviolet‐visible spectroscopy confirmed ZnONP formation, with a characteristic absorption peak at 372–377 nm, indicative of ZnO bandgap transitions. Fourier‐transform infrared spectroscopy confirmed colostrum coating by showing shifts in Zn–O bond peaks (400–500 cm−1) and amide I (1616.2 cm−1) and amide II (1547.1 cm−1) bands. Scanning electron microscopy revealed granular nanoparticles (78.79–81.20 nm), increasing to 88 nm after coating. Energy‐dispersive X‐ray spectroscopy detected zinc, oxygen, carbon, and calcium, with an additional magnesium peak attributed to colostrum. X‐ray diffraction confirmed the crystalline wurtzite structure with peaks in the 30° to 40° range. Zeta potential analysis indicated improved colloidal stability with colostrum. C–ZnONPs maintained 14‐day stability in fetal bovine serum via protein corona‐mediated steric effects. Antioxidant activity using the 2,2‐diphenyl‐1‐picrylhydrazyl assay showed G. asiatica extract had the lowest half‐maximal inhibitory concentration (IC₅₀) (5.86 ± 0.04 μg/mL), followed by C–ZnONPs (11.72 ± 0.02 μg/mL), outperforming ascorbic acid and uncoated ZnONPs. Antibacterial assays against Staphylococcus aureus, Escherichia coli, Salmonella typhi, and Klebsiella pneumoniae showed C–ZnONPs had the highest inhibition zones (13–22 mm). C–ZnONPs also showed dose‐dependent cytotoxicity against HeLa cells (IC₅₀ ≈ 34.09 μg/mL). These findings validate the successful eco‐friendly synthesis and coating of ZnONPs, highlighting their potential in nanomedicine, catalysis, and targeted drug delivery.
- 16 September 2025
- Published by Wiley in Applied Organometallic Chemistry
- Vol. 39 (10)
Eco‐Friendly ZnO Nanoparticle Synthesis and Colostrum Coating: Structural Insights and Biomedical Potential
The eco‐friendly synthesis of zinc oxide nanoparticles (ZnONPs) using Grewia asiatica stem extract and their subsequent coating with freeze‐dried bovine colostrum powder was explored for biomedical and environmental applications. This study investigated the role of phytochemicals as natural reducing and stabilizing agents in ZnONP synthesis, while also evaluating the structural and functional impact of colostrum coating. Ultraviolet‐visible spectroscopy confirmed ZnONP formation, with a characteristic absorption peak at 372–377 nm, indicative of ZnO bandgap transitions. Fourier‐transform infrared spectroscopy confirmed colostrum coating by showing shifts in Zn–O bond peaks (400–500 cm−1) and amide I (1616.2 cm−1) and amide II (1547.1 cm−1) bands. Scanning electron microscopy revealed granular nanoparticles (78.79–81.20 nm), increasing to 88 nm after coating. Energy‐dispersive X‐ray spectroscopy detected zinc, oxygen, carbon, and calcium, with an additional magnesium peak attributed to colostrum. X‐ray diffraction confirmed the crystalline wurtzite structure with peaks in the 30° to 40° range. Zeta potential analysis indicated improved colloidal stability with colostrum. C–ZnONPs maintained 14‐day stability in fetal bovine serum via protein corona‐mediated steric effects. Antioxidant activity using the 2,2‐diphenyl‐1‐picrylhydrazyl assay showed G. asiatica extract had the lowest half‐maximal inhibitory concentration (IC₅₀) (5.86 ± 0.04 μg/mL), followed by C–ZnONPs (11.72 ± 0.02 μg/mL), outperforming ascorbic acid and uncoated ZnONPs. Antibacterial assays against Staphylococcus aureus, Escherichia coli, Salmonella typhi, and Klebsiella pneumoniae showed C–ZnONPs had the highest inhibition zones (13–22 mm). C–ZnONPs also showed dose‐dependent cytotoxicity against HeLa cells (IC₅₀ ≈ 34.09 μg/mL). These findings validate the successful eco‐friendly synthesis and coating of ZnONPs, highlighting their potential in nanomedicine, catalysis, and targeted drug delivery.
- Open Access
- 31 October 2024
- Published by Oriental Scientific Publishing Company in Oriental Journal of Chemistry
- Vol. 40 (5) , 1440-1448
2D-QSAR Assisted Design, and Molecular Docking of Novel Indole Derivates as Anti-Cancer Agents
CADD is an important aspect of the any currently employed drug discovery process for a medicinal chemist. In the current study, research was initiated with a two dimensional Quantitative Structural Activity Relationship (QSAR) model generation through previously synthesized compounds. The 2-D QSAR model generated is then engaged for the predicting of the activity of our proposed compounds to be synthesized. This ligand-based approach of computer aided drug designing (CADD) is complimented further with the molecular docking simulations. Molecular docking of our proposed compounds was done to study the interaction of these compounds with the target protein i.e. tyrosine kinase receptor. Almost all the compounds showed significant results. Among them the most potent compound is SSIV which has -11.8 K/Cal/Mole.
- 31 October 2024
- Published by Oriental Scientific Publishing Company in Oriental Journal of Chemistry
- Vol. 40 (5) , 1440-1448
Open Access2D-QSAR Assisted Design, and Molecular Docking of Novel Indole Derivates as Anti-Cancer Agents
CADD is an important aspect of the any currently employed drug discovery process for a medicinal chemist. In the current study, research was initiated with a two dimensional Quantitative Structural Activity Relationship (QSAR) model generation through previously synthesized compounds. The 2-D QSAR model generated is then engaged for the predicting of the activity of our proposed compounds to be synthesized. This ligand-based approach of computer aided drug designing (CADD) is complimented further with the molecular docking simulations. Molecular docking of our proposed compounds was done to study the interaction of these compounds with the target protein i.e. tyrosine kinase receptor. Almost all the compounds showed significant results. Among them the most potent compound is SSIV which has -11.8 K/Cal/Mole.
- Open Access
- 1 July 2024
- Published by Manuscript Technomedia LLP in International Journal of Pharmaceutical Investigation
- Vol. 14 (3) , 696-701
Zebrafish as a Fascinating Animal Model: A Robust Platform for in vivo Screening for Biomedical Research
Background Zebrafish have emerged as an invaluable asset in biomedical research, particularly in comparison to other vertebrate models employed for studying human ailments. Their efficacy in large-scale studies of genetic variations and drug testing has been well-established. Recent advancements in CRISPR and next-generation sequencing have further boosted zebrafish-based disease modeling, enhancing our comprehension of the biological underpinnings of hereditary human diseases. Such efforts are critical for developing targeted therapies that offer innovative diagnostic and treatment options. Materials and Methods We extensively examined original articles and papers from prominent databases such as PubMed, SCOPUS, Science Direct, and PubMed Central. This analysis included a comprehensive review of the articles, their citations, and cross-references. To identify relevant articles, we employed a variety of keywords, including but not limited to: Zebrafish applications, toxicity studies involving Zebrafish, CRISPR technology applications in Zebrafish research, substances utilized in developmental biology studies with Zebrafish, and various models employed in Zebrafish research. Results In the medical field, zebrafish research has made strides in various areas, including developmental disorders, mental illnesses, and metabolic diseases. A growing trend involves studying an expanding spectrum of risk genes linked to neurological disorders using zebrafish as a model system. Zebrafish possess unique traits that make them an ideal choice for this purpose. For instance, their active partner growth of translucent embryos allows direct observation of the developing brain during early stages, providing valuable insights into developmental processes. Additionally, the large number of progenies zebrafish produce significantly enhances controllability, making them highly effective for therapeutic testing aimed at identifying specific molecular effectors of simple behavioral genetic traits. Conclusion The exceptional attributes of zebrafish make them a potent and versatile tool for medical research. Their contributions have been instrumental in advancing our understanding of human diseases and developing potential treatments. As a result, zebrafish continue to play a pivotal role in biomedical research, propelling progress in personalized medicine and the pursuit of improved treatments for a wide range of health conditions.
- 1 July 2024
- Published by Manuscript Technomedia LLP in International Journal of Pharmaceutical Investigation
- Vol. 14 (3) , 696-701
Open AccessZebrafish as a Fascinating Animal Model: A Robust Platform for in vivo Screening for Biomedical Research
Background Zebrafish have emerged as an invaluable asset in biomedical research, particularly in comparison to other vertebrate models employed for studying human ailments. Their efficacy in large-scale studies of genetic variations and drug testing has been well-established. Recent advancements in CRISPR and next-generation sequencing have further boosted zebrafish-based disease modeling, enhancing our comprehension of the biological underpinnings of hereditary human diseases. Such efforts are critical for developing targeted therapies that offer innovative diagnostic and treatment options. Materials and Methods We extensively examined original articles and papers from prominent databases such as PubMed, SCOPUS, Science Direct, and PubMed Central. This analysis included a comprehensive review of the articles, their citations, and cross-references. To identify relevant articles, we employed a variety of keywords, including but not limited to: Zebrafish applications, toxicity studies involving Zebrafish, CRISPR technology applications in Zebrafish research, substances utilized in developmental biology studies with Zebrafish, and various models employed in Zebrafish research. Results In the medical field, zebrafish research has made strides in various areas, including developmental disorders, mental illnesses, and metabolic diseases. A growing trend involves studying an expanding spectrum of risk genes linked to neurological disorders using zebrafish as a model system. Zebrafish possess unique traits that make them an ideal choice for this purpose. For instance, their active partner growth of translucent embryos allows direct observation of the developing brain during early stages, providing valuable insights into developmental processes. Additionally, the large number of progenies zebrafish produce significantly enhances controllability, making them highly effective for therapeutic testing aimed at identifying specific molecular effectors of simple behavioral genetic traits. Conclusion The exceptional attributes of zebrafish make them a potent and versatile tool for medical research. Their contributions have been instrumental in advancing our understanding of human diseases and developing potential treatments. As a result, zebrafish continue to play a pivotal role in biomedical research, propelling progress in personalized medicine and the pursuit of improved treatments for a wide range of health conditions.
- 1 July 2024
- Published by Bentham Science Publishers Ltd. in Current Cancer Therapy Reviews
- Vol. 20 (4) , 372-385
A Review on Indole as a Cardinal Scaffold for Anticancer Drugs Development
Chemotherapy is the mainstay of therapeutic cancer therapy; however, development of resistance typically makes it less effective. There are continuous efforts by the researchers to find novel lead compounds with potent anti-cancer activity. Generally, synthetic or natural heterocyclic compounds have been investigated in detail as a scaffold for cancer therapeutics. Among them, indole owing to its unique physiochemical and biological properties provides a promising platform for the development of pharmacaphore for drugs development against cancer, acting via various mechanisms. Till now, several indole based derivatives have been identified as anti-cancer agents which are either being used in clinics or are in various phases of clinical trials, suggesting their importance in anti-cancer drug development. These anti-cancer drugs have been classified into different classes depending upon their mechanism of action. For example, histone deacetylase inhibitors (HDAC inhibitors), silent mating type information regulation 2 homolog (SIRT) inhibitors, tubulin inhibitors, proviral insertion site in moloney murine leukemia virus (Pim) inhibitors, DNA Topoisomerase inhibitors, and kinase inhibitors. In this review, the authors approach is to compile the recent development on indole-based anti-cancer drugs and provide an insight into the respective structure activity relationships (SARs) of the compounds. We hope the review will provide a thorough understanding to the reader and guide to develop novel and potent indole based anticancer agents against drug-sensitive and drug-resistant cancer in future.
- 1 July 2024
- Published by Bentham Science Publishers Ltd. in Current Cancer Therapy Reviews
- Vol. 20 (4) , 372-385
A Review on Indole as a Cardinal Scaffold for Anticancer Drugs Development
Chemotherapy is the mainstay of therapeutic cancer therapy; however, development of resistance typically makes it less effective. There are continuous efforts by the researchers to find novel lead compounds with potent anti-cancer activity. Generally, synthetic or natural heterocyclic compounds have been investigated in detail as a scaffold for cancer therapeutics. Among them, indole owing to its unique physiochemical and biological properties provides a promising platform for the development of pharmacaphore for drugs development against cancer, acting via various mechanisms. Till now, several indole based derivatives have been identified as anti-cancer agents which are either being used in clinics or are in various phases of clinical trials, suggesting their importance in anti-cancer drug development. These anti-cancer drugs have been classified into different classes depending upon their mechanism of action. For example, histone deacetylase inhibitors (HDAC inhibitors), silent mating type information regulation 2 homolog (SIRT) inhibitors, tubulin inhibitors, proviral insertion site in moloney murine leukemia virus (Pim) inhibitors, DNA Topoisomerase inhibitors, and kinase inhibitors. In this review, the authors approach is to compile the recent development on indole-based anti-cancer drugs and provide an insight into the respective structure activity relationships (SARs) of the compounds. We hope the review will provide a thorough understanding to the reader and guide to develop novel and potent indole based anticancer agents against drug-sensitive and drug-resistant cancer in future.